VeriMomDois-je éviter propylene glycol myristate pendant la grossesse ? | VeriMom
No authoritative reproductive hazard assessment (no harmonised H360/H361 in Annex VI was confirmed; no SCCS or CIR safety assessment indicating reproductive toxicity). As a fatty ester emollient, no pregnancy-specific toxicity data were found in available regulatory sources. Topical dermal absorption is expected to be low but measurable for such esters, so exposure is scored as low (e=1). Sources consulted: ECHA C&L (notifications), PubChem, CosIng, CIR, PubMed (no relevant reproductive studies found).
ECHA regulatory hazard statements
- •H361
What to use instead
Pregnancy-safe ingredients that serve a similar function:
FAQ
- propylene glycol myristate est-il sûr pendant la grossesse ?
- No authoritative reproductive hazard assessment (no harmonised H360/H361 in Annex VI was confirmed; no SCCS or CIR safety assessment indicating reproductive toxicity). As a fatty ester emollient, no pregnancy-specific toxicity data were found in available regulatory sources. Topical dermal absorption is expected to be low but measurable for such esters, so exposure is scored as low (e=1). Sources consulted: ECHA C&L (notifications), PubChem, CosIng, CIR, PubMed (no relevant reproductive studies found).
- propylene glycol myristate est-il sûr pendant l'allaitement ?
- No evidence of reproductive or lactation-specific toxicity in authoritative reviews; no known mechanism for transfer into breast milk. Dermal absorption expected low but measurable leading to low maternal systemic exposure (e=1). Sources: same as for pregnancy (ECHA C&L self-notifications, PubChem, CosIng, CIR, PubMed).
- propylene glycol myristate est-il sûr pour la peau de bébé ?
- No infant-specific toxicity or developmental data identified. Because infant skin has higher permeability and surface-area-to-weight, exposure score is increased by +1 relative to adults (adult e=1 → infant e=2). No evidence supports increased hazard or a reproductive mechanism in infants. Sources: CosIng, PubChem, ECHA C&L, PubMed (no infant-specific studies found).
- Comment VeriMom évalue-t-il propylene glycol myristate ?
- VeriMom évalue propylene glycol myristate à 33/100 (risque élevé) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à propylene glycol myristate pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à propylene glycol myristate basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.